Skip to main content
. 2012 Jun;15(6):581–587. doi: 10.1089/jmf.2011.0308

Table 1.

Anti–Herpes Simplex Virus Type 1 and Anti–Herpes Simplex Virus Type 2 Activity of Apple Pomace Extracts and Standards of Identified Metabolites

 
 
Antiviral activity
 
Sample Cytotoxicity CC50 (μg/mL) Anti–HSV-1 EC50 (μg/mL) SI Anti–HSV-2 EC50 (μg/mL) SI
Pomace M 11,827±1852 946.9±19.1 12.5 757.0±60.8 15.6
Pomace DR 15,251±3503 1012±186 15.1 541.8±59.1 28.1
Pomace C 9466±260 >1600 <5.92 337.4±25.2 28.0
Procyanidin B2 323.6±33.2 33.23±1.33 9.74 24.22±1.2 13.4
Quercitrin 1211±17.3 560.9±31.6 2.16 514.3±34.2 2.35
Isoquercitrin 453.4±69.7 >300 <2 >300 <2
Chlorogenic acid 273.9±14.6 >200 <2 >200 <2
Cinnamic acid 550.3±12.7 >400 <2 >400 <2
Protocatechuic acid 328.2±60.3 >200 <2 >200 <2
Cafeic acid 80.36±7.75 >50 <2 >50 <2
Phloridzin >1000 >500 N/D >500 N/D
Hyperin >1000 >500 N/D >500 N/D
ACV 1454±120 0.9±0.01 1615 0.8±0.12 1817

Data are presented as the mean values from three independent experiments with their standard deviations. ACV served as positive control.

CC50, mean cytotoxic concentration; HSV, herpes simplex virus type; EC50, mean effective concentration; SI, selectivity index; M, Meana; DR, De la Riega; C, Carrió; N/D, not determined; ACV, acyclovir.